Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Market scope & definitions
1.3 Base estimates and calculations
1.3.1 North America
1.3.2 Europe
1.3.3 Asia Pacific
1.3.4 Latin America
1.3.5 MEA
1.4 Forecast calculations
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Assisted reproductive technology (ART) industry 360° synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Type trends
2.1.3 End user/provider trends
2.1.4 Regional trends
Chapter 3 Assisted Reproductive Technology (ART) Industry Insights
3.1 Industry landscape
3.2 Pricing analysis 2018 – 2032
3.2.1 Procedure pricing analysis, by region
3.2.1.1 North America
3.2.1.2 Europe
3.2.1.3 Asia Pacific
3.2.1.4 Latin America
3.2.1.5 Middle East & Africa
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Rising prevalence of infertility across population base
3.3.1.2 Demographical shift towards acceptance of assisted reproductive technology (ART)
3.3.1.3 Technological advancements in assisted reproductive technology
3.3.1.4 Rising awareness regarding assisted reproductive technology
3.3.2 Industry pitfalls & challenges
3.3.2.1 High cost of procedures
3.3.2.2 Social barriers and lack of advanced infrastructure in emerging countries
3.4 Growth potential analysis
3.4.1 By type
3.4.2 By end user/provider
3.5 COVID- 19 impact analysis
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.6.3 Asia Pacific
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape
4.1 Introduction
4.1.1 The Cooper Companies Inc.
4.1.2 Vitrolife AB
4.1.3 LABORATOIRE CCD
4.2 Competitive dashboard, 2021
4.3 Company matrix analysis, 2021
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategic outlook matrix
Chapter 5 Assisted Reproductive Technology (ART) Market, By Type
5.1 Key type trends
5.2 Product
5.2.1 Media
5.2.2 Catheters
5.2.3 Needles
5.2.4 Vitrification Devices
5.2.5 Incubators
5.2.6 Others
5.3 Procedure
5.3.1 Fresh Donor
5.3.2 Fresh Nondonor
5.3.3 Frozen Donor
5.3.4 Frozen Nondonor
5.3.5 Embryo/Egg Banking
5.3.6 By procedure technology
5.3.6.1 In-vitro fertilization (IVF)
5.3.6.1.1 IVF with Intracytoplasmic Sperm Injection (ICSI)
5.3.6.1.2 IVF without ICSI
5.3.6.2 Artificial Insemination - Intrauterine Insemination (AI-IUI)
5.3.6.3 Frozen Embryo Replacement (FER)
5.3.6.4 Others
Chapter 6 Assisted Reproductive Technology (ART) Market, By End User/Provider
6.1 Key end user/provider trends
6.2 Hospitals
6.3 Fertility clinics
6.4 Others
Chapter 7 Assisted Reproductive Technology (ART) Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Italy
7.3.5 Spain
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.6 Middle East & Africa
7.6.1 South Africa
7.6.2 Egypt
Chapter 8 Company Profiles
8.1 The Cooper Companies Inc. (CooperSurgical)
8.2 Hamilton Thorne, Inc.
8.3 LABORATOIRE CCD
8.4 Fujifilm Irvine scientific (Fujifilm Holdings Corporation)
8.5 Nidacon International AB
8.6 Vitrolife AB
8.7 Thermo Fisher Scientific
8.8 Olympus Corporation
8.9 KITAZATO
8.10 Gynotec
8.11 Western Fertility Institute
8.12 Reproductive Medicine and Surgery Center of Virginia
8.13 SevenHills Hospital
8.14 Fertility Clinic Tokyo
8.15 INDIRA IVF Hospital
8.16 Tambre Fertility Clinic Madrid